Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $31.18B.
ENTERPRISE VALUE (EV)
$31.18B
ResMed Inc.
Market Cap
$31.83B
Enterprise Value (EV)
$31.18B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ResMed Inc. (RMD) | $31.83B | $31.18B |
| Zoetis Inc. (ZTS)vs › | $31.39B | $29.18B |
| Waters Corporation (WAT)vs › | $30.85B | $34.98B |
| Centene Corp. (CNC)vs › | $32.87B | $24.44B |
| GE HealthCare Technologies Inc. (GEHC)vs › | $33.04B | $40.41B |
| Biogen Inc. (BIIB)vs › | $30.60B | $37.79B |
| DexCom, Inc. (DXCM)vs › | $33.10B | $32.27B |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $28.91B | $28.89B |
| Mettler-Toledo International Inc. (MTD)vs › | $28.84B | $30.95B |
| Medline Inc. (MDLN)vs › | $28.78B | $40.19B |
Market Cap
$31.83B
Total Debt
$825.92M
Cash
$1.47B
Enterprise Value
$31.18B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
